Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sexually Transmitted Diseases

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 24 articles: HTML format

Single Articles

January 2024
1. WANG Y, He M, He T, Ouyang X, et al
   Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
   Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
   PubMed     Abstract available
   
   
   
2. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
   Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
   Br J Cancer. 2024 Jan 8. doi: 10.1038/s41416-023-02521.
   PubMed    
   
   
   November 2023
3. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
   Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
   Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
   PubMed     Abstract available
   
   
   October 2023
4. LO CIGNO I, Calati F, Girone C, Borgogna C, et al
   SIRT1 is an actionable target to restore p53 function in HPV-associated cancer therapy.
   Br J Cancer. 2023 Oct 14. doi: 10.1038/s41416-023-02465.
   PubMed     Abstract available
   
   
   August 2023
5. CUSCHIERI K, Palmer T, Graham C, Cameron R, et al
   The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland.
   Br J Cancer. 2023 Aug 10. doi: 10.1038/s41416-023-02386.
   PubMed     Abstract available
   
   
   April 2023
6. VERHOEF L, Bleeker MCG, Polman N, Steenbergen RDM, et al
   Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
   Br J Cancer. 2023 Apr 26:1-8. doi: 10.1038/s41416-023-02277.
   PubMed     Abstract available
   
   
   
7. KAMAL M, Lameiras S, Deloger M, Morel A, et al
   Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
   Br J Cancer. 2023 Apr 13. doi: 10.1038/s41416-023-02261.
   PubMed    
   
   
   
8. STOGBAUER F, Beck S, Ourailidis I, Hess J, et al
   Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
   Br J Cancer. 2023 Apr 12. doi: 10.1038/s41416-023-02240.
   PubMed     Abstract available
   
   
   March 2023
9. MITTELSTADT S, Kelemen O, Admard J, Gschwind A, et al
   Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse.
   Br J Cancer. 2023 Mar 27. doi: 10.1038/s41416-023-02233.
   PubMed     Abstract available
   
   
   
10. GILHAM C, Sargent A, Crosbie EJ, Peto J, et al
    Long-term risks of invasive cervical cancer following HPV infection: follow-up of two screening cohorts in Manchester.
    Br J Cancer. 2023 Mar 23. doi: 10.1038/s41416-023-02227.
    PubMed     Abstract available
    
    
    December 2022
11. COSTA S, Verberckmoes B, Castle PE, Arbyn M, et al
    Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
    Br J Cancer. 2022 Dec 14. doi: 10.1038/s41416-022-02094.
    PubMed     Abstract available
    
    
    August 2022
12. AASBO G, Trope A, Nygard M, Christiansen IK, et al
    HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Br J Cancer. 2022 Aug 23. pii: 10.1038/s41416-022-01954.
    PubMed     Abstract available
    
    
    June 2022
13. HERBST J, Pantel K, Effenberger K, Wikman H, et al
    Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions.
    Br J Cancer. 2022 Jun 20. pii: 10.1038/s41416-022-01868.
    PubMed     Abstract available
    
    
    March 2022
14. REBOLJ M, Pesola F, Mathews C, Mesher D, et al
    The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot.
    Br J Cancer. 2022 Mar 26. pii: 10.1038/s41416-022-01791.
    PubMed     Abstract available
    
    
    November 2021
15. DICK S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, et al
    Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping.
    Br J Cancer. 2021 Nov 6. pii: 10.1038/s41416-021-01614.
    PubMed     Abstract available
    
    
    October 2021
16. MANLEY K, Patel A, Pawade J, Glew S, et al
    The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3.
    Br J Cancer. 2021 Oct 29. pii: 10.1038/s41416-021-01539.
    PubMed     Abstract available
    
    
    September 2021
17. IDEN M, Tsaih SW, Huang YW, Liu P, et al
    Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.
    Br J Cancer. 2021 Sep 15. pii: 10.1038/s41416-021-01545.
    PubMed     Abstract available
    
    
    June 2021
18. WAGNER S, Prigge ES, Wuerdemann N, Reder H, et al
    Correction: Evaluation of p16(INK4a) expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation.
    Br J Cancer. 2021 Jun 10. pii: 10.1038/s41416-021-01457.
    PubMed    
    
    
    March 2021
19. OLIVA M, Schneeberger PHH, Rey V, Cho M, et al
    Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
    Br J Cancer. 2021 Mar 10. pii: 10.1038/s41416-020-01253.
    PubMed     Abstract available
    
    
    
20. EINBOND LS, Zhou J, Wu HA, Mbazor E, et al
    A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA.
    Br J Cancer. 2021;124:901-913.
    PubMed     Abstract available
    
    
    December 2020
21. PATEL U, Pandey M, Kannan S, Samant TA, et al
    Prognostic and predictive significance of nuclear HIF1alpha expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
    Br J Cancer. 2020;123:1757-1766.
    PubMed     Abstract available
    
    
    November 2020
22. KAMAL M, Lameiras S, Deloger M, Morel A, et al
    Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
    Br J Cancer. 2020 Nov 16. pii: 10.1038/s41416-020-01153.
    PubMed     Abstract available
    
    
    October 2020
23. ARROYO MUHR LS, Lagheden C, Lei J, Eklund C, et al
    Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR.
    Br J Cancer. 2020 Oct 6. pii: 10.1038/s41416-020-01111.
    PubMed     Abstract available
    
    
    November 2019
24. SABATINI ME, Chiocca S
    Human papillomavirus as a driver of head and neck cancers.
    Br J Cancer. 2019 Nov 11. pii: 10.1038/s41416-019-0602.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.